[go: up one dir, main page]

ATE173918T1 - Steroide enthaltende pharmazeutische granulate - Google Patents

Steroide enthaltende pharmazeutische granulate

Info

Publication number
ATE173918T1
ATE173918T1 AT93203476T AT93203476T ATE173918T1 AT E173918 T1 ATE173918 T1 AT E173918T1 AT 93203476 T AT93203476 T AT 93203476T AT 93203476 T AT93203476 T AT 93203476T AT E173918 T1 ATE173918 T1 AT E173918T1
Authority
AT
Austria
Prior art keywords
carrier
mixture
optionally
granules
desogestrel
Prior art date
Application number
AT93203476T
Other languages
English (en)
Inventor
Jan Hendrik Dopper
Der Ven Cornelis Josephus Van
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27578967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE173918(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE173918T1 publication Critical patent/ATE173918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
AT93203476T 1992-09-04 1993-12-10 Steroide enthaltende pharmazeutische granulate ATE173918T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US07/941,026 US5395627A (en) 1992-09-04 1992-09-04 Pharmaceutical granulate
EP93203476A EP0657161B1 (de) 1992-09-04 1993-12-10 Steroide enthaltende pharmazeutische Granulate
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett
FI935584A FI111221B (fi) 1992-09-04 1993-12-13 Menetelmä farmaseuttisten rakeiden valmistamiseksi
NZ250443A NZ250443A (en) 1992-09-04 1993-12-13 Preparation of film coated, steroid-loaded granules
CA002111320A CA2111320A1 (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
ZA939337A ZA939337B (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
AU52391/93A AU672447B2 (en) 1992-09-04 1993-12-14 Pharmaceutical granulate
JP32229093A JP3720385B2 (ja) 1992-09-04 1993-12-21 医薬顆粒
CN93121510A CN1050043C (zh) 1992-09-04 1993-12-29 药物颗粒

Publications (1)

Publication Number Publication Date
ATE173918T1 true ATE173918T1 (de) 1998-12-15

Family

ID=27578967

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93203476T ATE173918T1 (de) 1992-09-04 1993-12-10 Steroide enthaltende pharmazeutische granulate

Country Status (15)

Country Link
US (2) US5395627A (de)
EP (1) EP0657161B1 (de)
JP (1) JP3720385B2 (de)
CN (1) CN1050043C (de)
AT (1) ATE173918T1 (de)
AU (1) AU672447B2 (de)
CA (1) CA2111320A1 (de)
DE (1) DE69322396T2 (de)
DK (1) DK0657161T3 (de)
ES (1) ES2125300T3 (de)
FI (1) FI111221B (de)
GR (1) GR3029273T3 (de)
NO (1) NO306928B1 (de)
NZ (1) NZ250443A (de)
ZA (1) ZA939337B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
IL113816A (en) * 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical compositions containing desogestrel their preparation and use
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
KR100421526B1 (ko) * 1995-06-22 2004-05-20 악조 노벨 엔.브이. 압축건식과립화데소게스트렐정제
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
PT927556E (pt) * 1997-09-23 2000-12-29 Akzo Nobel Nv Unidades de dosagem de esteroides com um revestimento para selagem destes
WO2000059920A2 (en) * 1999-04-06 2000-10-12 Akzo Nobel N.V. Orally active 7.alpha.-alkyl androgens
ES2253451T3 (es) * 2000-12-14 2006-06-01 Ortho-Mcneil Pharmaceutical, Inc. Productos a base de hormona esteroide y sus procedimientos de fabricacion.
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
DK1275377T3 (da) * 2001-07-11 2003-10-06 Applied Pharma Res Granulater, der indeholder fedtopløselige stoffer, og en fremgangsmåde til fremstilling deraf
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
EP1853272A1 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
US20070248665A1 (en) * 2006-04-24 2007-10-25 Sherman Bernard C Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
US10952968B2 (en) * 2012-05-14 2021-03-23 Shionogi & Co., Ltd. Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
US10835495B2 (en) 2012-11-14 2020-11-17 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same
CN103271927A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进口服避孕药含量均匀性三级稀释法的工艺
CN103271928A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进去氧孕烯稳定性的处方工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
NO934584D0 (no) 1993-12-13
US5395627A (en) 1995-03-07
US5527543A (en) 1996-06-18
DE69322396T2 (de) 1999-07-29
AU5239193A (en) 1995-07-13
FI935584L (fi) 1995-06-14
NO934584L (no) 1995-06-14
JP3720385B2 (ja) 2005-11-24
ES2125300T3 (es) 1999-03-01
ZA939337B (en) 1994-10-13
FI935584A0 (fi) 1993-12-13
JPH07196513A (ja) 1995-08-01
EP0657161A1 (de) 1995-06-14
AU672447B2 (en) 1996-10-03
NO306928B1 (no) 2000-01-17
CN1104487A (zh) 1995-07-05
NZ250443A (en) 1995-07-26
CN1050043C (zh) 2000-03-08
CA2111320A1 (en) 1995-06-14
GR3029273T3 (en) 1999-05-28
DE69322396D1 (de) 1999-01-14
FI111221B (fi) 2003-06-30
DK0657161T3 (da) 1999-08-16
EP0657161B1 (de) 1998-12-02

Similar Documents

Publication Publication Date Title
DE69322396D1 (de) Steroide enthaltende pharmazeutische Granulate
DE59403717D1 (de) Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AU2110892A (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
AU1076492A (en) Novel formulations of crop protection agents
BE900241A (fr) Procede de preparation d'ester de a-acetoxyethyle de cefuroxime.
KR880001237B1 (ko) 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법
DE69310052D1 (de) Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
US20050245496A1 (en) High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
DE60031557D1 (de) Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
US3133858A (en) Stable thiobarbituric acid solution
US3627886A (en) Methods of solubilizing coumermycin employing urea, dimethylacetamide or mixtures thereof
EP0401894B1 (de) Gefriergetrocknete pulverförmige Cyclophosphamidzusammensetzung sowie Verfahren zu deren Herstellung
KR950016749A (ko) 약제용 과립 및 그 제조 방법
Maulding Solid-state dispersions employing urethan
Fahrenholtz et al. Steroidal imidazole-1-carboxylic acid esters
GB2008096A (en) (2-Oxo-pyrrolidine-1)- and (2-oxo- piperidine-1) carboxylic acid hydrazides, process for the manufacture thereof, and pharmaceutical preparations containing them
JPH03178906A (ja) 包接化合物の製造方法
EP0387655B1 (de) Stabilisierung von Polyprenylverbindungen
GEP20002095B (en) Antracycline Disaccharides, Process for Their Preparation and Pharmaceutical Compositions
US3629240A (en) 17beta-(1-cycloalkenyl) oxy-2alpha 3alpha-epithio-5alpha-androstanes
US3869481A (en) 17alpha-alkanoyloxy-6alpha-methyl-3beta-trialkyl-siloxypregn-4-en-20-ones
JPS5655362A (en) Polyfunctional azide compound and its preparation
JPS54125651A (en) Monocyclic beta-lactam derivative and its preparation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked